Endocannabinoid Signaling Mediates Oxytocin-driven Social Reward

Autism

Key Findings

The results indicate that anandamide-mediated signaling at CB1 receptors, driven by oxytocin, controls social reward. Deficits in this signaling mechanism may contribute to social impairment in autism spectrum disorders and might offer an avenue to treat these conditions.

Information and Links


Link: Endocannabinoid Signaling Mediates Oxytocin-driven Social Reward

Year: 2015

DOI: 10.1073/pnas.1509795112


Ratings

(How Ratings Work)

Autism — 2


Possible to probable range of efficacy of cannabis for treatment of Autism according to the results found in this study.

Drugs Used

Anadamide and oxytocin.